Predict your next investment

Corporation
exactushemp.com

See what CB Insights has to offer

Partners & Customers

1

About Exactus

Exactus is a healthcare company pursuing opportunities in hemp-derived cannabidiol.

Exactus Headquarter Location

80 NE 4th Avenue Suite 28

Delray Beach, Florida, 33483,

United States

804-205-5036

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Exactus

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Exactus in 1 Expert Collection, including Cannabis.

C

Cannabis

3,619 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Latest Exactus News

Colorado CBD company takes steps toward IPO on Nasdaq

Oct 13, 2021

Exactus, Inc., which will soon be rebranded as Panacea Life Sciences Holdings, a publicly traded, vertically integrated CBD company based in Golden, Colorado, announced Monday it will pursue an initial public offering on the Nasdaq market. Colorado CBD company takes steps toward IPO on Nasdaq is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs

Exactus Acquisitions

4 Acquisitions

Exactus acquired 4 companies. Their latest acquisition was Panacea Life Sciences on July 01, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/1/2021

Loan

$0.25M

Acq - Pending

1

10/15/2019

Subscribe to see more

$99M

Subscribe to see more

10

8/2/2019

Subscribe to see more

$991

$99M

Subscribe to see more

10

3/25/2019

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/1/2021

10/15/2019

8/2/2019

3/25/2019

Investment Stage

Loan

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

Total Funding

$0.25M

$99M

$99M

$99M

Note

Acq - Pending

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

Exactus Partners & Customers

1 Partners and customers

Exactus has 1 strategic partners and customers. Exactus recently partnered with Canntab Therapeutics on November 11, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

11/20/2019

Licensee

Canntab Therapeutics

Canada

Canntab Achieves Key Milestone: Canntab Enters Into Supply & Distribution Agreements With Exactus for the Purchase of Hemp-Derived CBD Oil and the Distribution of Canntab's Hard Pill Formulations in the United States

TORONTO , Nov. 20 , 2019 / PRNewswire / - Canntab Therapeutics Limited , the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application , today announced the signing of a supply agreement and a non-exclusive distribution and profit sharing agreement with Exactus Inc. , a farm operator and manufacturer of hemp-derived phytocannabinoid products in the U.S.

1

Date

11/20/2019

Type

Licensee

Business Partner

Canntab Therapeutics

Country

Canada

News Snippet

Canntab Achieves Key Milestone: Canntab Enters Into Supply & Distribution Agreements With Exactus for the Purchase of Hemp-Derived CBD Oil and the Distribution of Canntab's Hard Pill Formulations in the United States

TORONTO , Nov. 20 , 2019 / PRNewswire / - Canntab Therapeutics Limited , the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application , today announced the signing of a supply agreement and a non-exclusive distribution and profit sharing agreement with Exactus Inc. , a farm operator and manufacturer of hemp-derived phytocannabinoid products in the U.S.

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.